Joseph H. Wender, Director at IONIS PHARMACEUTICALS INC (IONS), sold 16,800 shares at $65.50 ($1.1M) on 2025-10-01, disclosed to the SEC on 2025-10-02.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IONS | SELL | 2025-09-04 | $1.6M | — | Filing → |
| IONS | SELL | 2019-03-20 | $796K | — | Filing → |
| IONS | SELL | 2018-05-11 | $1.3M | — | Filing → |